News
News
- Ascendis Pharma A/S Announces Phase 3 PaTHway Trial of TransCon™ PTH in Adults with Hypoparathyroidism Met Primary and All Key Secondary Endpoints
03/13/2022 / 22:53 - GlobeNewswire - Viridian Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Updates
03/10/2022 / 22:05 - GlobeNewswire - Dress for Success San Francisco Honors Groundbreaking “Bay Area Women in Power” Leading the Way to Support Others
03/10/2022 / 18:43 - GlobeNewswire - Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention
03/10/2022 / 14:47 - GlobeNewswire - ExCellThera announces first patient treated in Phase I/II trial of ECT-001 cell therapy for pediatric patients with high risk blood cancer
03/10/2022 / 14:04 - GlobeNewswire - SPEC Establishes Machine Learning Committee to Develop Vendor-Agnostic Benchmarks
03/10/2022 / 10:00 - GlobeNewswire - Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting
03/08/2022 / 22:30 - GlobeNewswire - Acer Therapeutics Secures up to $48.5 Million in Convertible Note and Secured Loan Financing Facilities
03/07/2022 / 12:15 - GlobeNewswire - Runway Growth Finance Corp. Reports Fourth Quarter and Fiscal Year Ended 2021 Financial Results
03/03/2022 / 22:23 - GlobeNewswire - Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S.
03/03/2022 / 13:30 - GlobeNewswire
Real-time